A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy. 2017

Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
Department of Esophageal Surgery, Tokyo Medical and Dental University, Japan.

OBJECTIVE Patients undergoing chemotherapy often develop distressing adverse effects such as oral mucositis and diarrhea. Nutritional support with elemental diet is effective against various gastrointestinal complications and may exert protective effects against adverse effects induced by chemotherapy. To evaluate the influence of elemental diet on chemotherapy-induced oral mucositis and diarrhea, we conducted a randomized control trial in patients with esophageal cancer undergoing chemotherapy. METHODS Twenty esophageal cancer patients receiving chemotherapy with 5-fluorouracil plus cisplatin were assigned randomly to one of the following two groups: (1) receiving elemental diet with Elental (one pack per day) for 14 days and (2) not receiving Elental during chemotherapy. The severity of oral mucositis and diarrhea was graded using clinical examination by doctors and a standard questionnaireon days 1-14. RESULTS Based on the analysis of the standard questionnaire, the distribution of the maximum severity of oral mucositis showed a statistically significant reduction in the Elental group (p=0.020), while clinical examination showed insignificant reduction but shift toward lower grade. In the Elental group, the incidence of oral mucositis (grade >=2) reduced consistently and the median grade was lower at all-time points. Regarding diarrhea, no difference was observed between the two groups based on the analysis of the standard questionnaire and clinical examination results. CONCLUSIONS This study illustrates the effectiveness of oral elemental diet in preventing oral mucositis during chemotherapy. This is a preliminary report and further study with larger patients groups should be devoted to optimization of efficacy.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005526 Food, Formulated Food and dietary formulations including elemental (chemically defined formula) diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, complete liquid diets, and supplemental liquid and solid diets. Diet, Chemically Defined,Diet, Elemental,Diet, Formula,Diet, Synthetic,Dietary Formulations,Chemically Defined Diet,Synthetic Diet,Chemically Defined Diets,Dietary Formulation,Diets, Chemically Defined,Diets, Elemental,Diets, Formula,Diets, Synthetic,Elemental Diet,Elemental Diets,Foods, Formulated,Formulated Food,Formulated Foods,Formulation, Dietary,Formulations, Dietary

Related Publications

Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
October 2016, JAMA oncology,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
January 2011, Clinical nurse specialist CNS,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
October 2007, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
June 2013, Clinical journal of oncology nursing,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
April 2011, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
January 2003, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
December 2010, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
April 2006, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
December 2015, The Cochrane database of systematic reviews,
Takuya Okada, and Yasuaki Nakajima, and Tetsuro Nishikage, and Tairo Ryotokuji, and Yutaka Miyawaki, and Akihiro Hoshino, and Yutaka Tokairin, and Kenro Kawada, and Kagami Nagai, and Tatsuyuki Kawano
June 2023, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
Copied contents to your clipboard!